News

In a study presented at ACG, investigators focus on quality of life improvements for patients with irritable bowel syndrome.

Dr. Fasipe shares about her experience at the National Organization for Rare Disease Summit 2021 as the opening plenary speaker.

Dr. Worobey suggested in his report that the vendor’s ties to the Huanan Seafood Wholesale Market strongly suggested the pandemic originated at the Wuhan market.

Investigators also noted that higher rates of infection were observed in Black patients.

More than 90% of patients in hypertension and lipid management accomplished their predetermined goals after completing the remote program.

Investigators called for prospective studies with longer time horizons to see if these associations persist throughout childhood.

To the investigators’ knowledge, the study offers insights into lesion presentations on undiagnosed adults with vitiligo.

Investigators recommended the development and validation of a screening tool for FAA that transcends the current food allergy-specific measures.

Investigators found that using virtual reality to reduce pain levels during operational hsyteroscopy was not effective.

After 1 year, 37% of patients had died and 65% of patients were readmitted to the hospital.

Bentracimab achieved the predetermined primary endpoint of immediate and sustained reversal of the antiplatelet effects of ticagrelor in the REVERSE-IT trial.

Despite this, asthma severity was not associated with higher risk of COVID-19.

Young smokers in 2017 were more likely to have other comorbid conditions including hypertension, diabetes, and obesity.

A new study from the American Heart Association Scientific Sessions 2021 found that atherosclerotic cardiovascular disease risk increases with sdLDL-C levels, regardless of sex or race.

Dr. Dhoot discusses data on visual acuity from the phase 3 KESTREL and KITE trials, comparing brolucizumab to aflibercept at 52 weeks.

Investigators said that patient-reported outcomes from the 2 abrocitinib groups showed greater efficacy than the dupilumab and placebo groups.

Hydroxyurea has been on the market for decades and yet it's underutilized as a treatment for sickle cell disease.

EaseVRx utilizes cognitive behavioral therapy and other behavioral therapy techniques.

There was a 135% reduction in platelet inhibition observed within 5-10 minutes following bentracimab infusion.

The Director of Retina Services at Wills Eye Hospital joins to discuss the historic FDA approval granted for a novel method of ophthalmic care: a permanent implant that allows for vision-saving formula therapy to treat the eye continually.

Dr. Khanani highlights data from MERLIN showing noninferiority of brolucizumab to aflibercept in nAMD treatment, but a higher rate of intraocular inflammation.

Treatment with statins, nitrates, dihydropyridines, verapamil, and proton-pump inhibitors were predictors of death or ischemic events for patients in the HGFR group.

Dr. Sheth discusses the data from the late-breaking Phase 2B ALTISSIMO study.

The least selected attributes were food and medication restrictions and A1c lowering followed by risk of diabetic ketoacidosis, risk of genital infection, and the avoidance of severe hypoglycemia.

Dr. Elewski hopes that in the future more clinicians will prescribe biologics such as secukinumab and etancercept for the treatment of psoriasis.

Though not all hemangioma last past 10 years old in pediatric patients, some untreated hemangioma are associated with high risk of ulceration.

Ropeginterferon Alfa-2b-NJFT (Besremi) is approved by the FDA for the treatment of polycythemia vera regardless of a patient's treatment history.

Certain biologics such as infliximab have aided psoriasis patients in the mitigation of symptoms from the COVID-19 virus.